Plasma Sclerostin Level & Treatment of Osteomalacia (OMSOST)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Ilhan Karacan, Clinical Associated Professor, Bagcilar Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT01553344
First received: March 12, 2012
Last updated: May 6, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2013
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)